Helping biotech and industry make the connection

RareKids-CAN partners with industry to strengthen and accelerate the pediatric rare disease clinical trials ecosystem across Canada. Through our coordinated national network of pediatric research sites, investigators, patient and family partners, and centralized operational supports, we help streamline study planning, feasibility assessments, harmonized ethics review, site start up and execution within Canada’s pediatric rare disease clinical trial landscape.

We can help you connect with the expertise, infrastructure, sites and research teams needed to move research forward. 

Benefits of partnering with RareKids-CAN

Faster site engagement

Accelerate study start-up through trusted investigator relationships and targeted outreach by our Clinical Trial Navigators, improving response rates and reducing delays. Through our tailored approach, we have achieved a 500% higher engagement rate with investigators and trial sites compared with traditional, one-by-one outreach approaches used by industry partners.

Reduced operational burden

Streamline site identification and investigator engagement with one coordinated process, minimizing duplication and saving valuable time and resources.

Simplified national access

Access Canada’s pediatric rare disease clinical trial community through a single point of contact, connecting you with investigators, experts, and trial sites nationwide.

Make informed decisions earlier

Gauge site interest, investigator availability, and study alignment early, helping you prioritize high potential sites and confidently plan your pediatric rare disease clinical trial.

How we support industry

    Incorporate the perspectives of patients and families into your clinical trial planning. RareKids-CAN facilitates meaningful engagement with patient partners to help ensure studies reflect community priorities, address real world needs, and support the development of more patient-centered pediatric rare disease clinical trials.